Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACP Injection Following Partial Meniscectomy
NCT02872753Phase 4Completed
- Sponsor
- Istituto Ortopedico Rizzoli
- Start
- Jul 2017
- Primary completion
- Aug 2017
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of autologous conditioned plasma in meniscal tear, sponsored by Istituto Ortopedico Rizzoli. Primary endpoints: International Knee Documentation Committee at 180 days and Visual Analogue Scale for pain at 180 days. Started Jul 2017; status: completed.
02
Drugs
autologous conditioned plasma
03
Conditions
meniscal tear
Beyond the preview
Go deeper on NCT02872753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02872753.